RDEA3170 PK/PD Study

Completed · Phase 1

Conditions studied: Gout

In brief

The purpose of this study is to examine the pharmacokinetic and pharmacodynamic effect of RDEA3170 when given as single or multiple doses

Key facts

Study ID
NCT02608710
Run by
Ardea Biosciences, Inc.
People needed
40
Starts
2015-11-01
Expected to finish
2016-04-01
Last updated by the study team
2016-09-02

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.